日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Subcutaneous Lenacapavir in People With Multidrug-Resistant HIV-1: 156 Week Results of the CAPELLA Study

皮下注射Lenacapavir治疗多重耐药HIV-1感染者:CAPELLA研究的156周结果

Ogbuagu, Onyema; Wiznia, Andrew; McGowan, Joseph P; Berger, Daniel S; Creticos, Catherine M; Hagins, Debbie; Hodge, Theo; Osiyemi, Olayemi; Sims, James; Wheeler, David A; Wang, Hui; Margot, Nicolas A; Dvory-Sobol, Hadas; Rhee, Martin S; Segal-Maurer, Sorana; Molina, Jean-Michel

The Effects of Cobicistat and Voriconazole on the Safety, Pharmacokinetics, and Pharmacodynamics of the TLR7 Agonist Vesatolimod in People with HIV

考比司他和伏立康唑对 HIV 感染者中 TLR7 激动剂维沙托利莫德的安全性、药代动力学和药效学的影响

Zheng, Yanan; Wire, Mary; Omange, Robert Were; deVries, Christiaan R; Zhang, Liao; Chen, Buyun; Huang, Susie S Y; Cruz, Kimberly; Hassman, Howard; Osiyemi, Olayemi; Rondon, Juan Carlos; Lim, Daina; West, Steve; Wen, Anita; Wallin, Jeffrey J; SenGupta, Devi; Cai, Yanhui

Bictegravir/emtricitabine/tenofovir alafenamide in adults with HIV-1 and end-stage kidney disease on chronic haemodialysis

比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺用于接受慢性血液透析的HIV-1合并终末期肾病成人患者

Eron, Joseph J; Ramgopal, Moti; Osiyemi, Olayemi; Mckellar, Mehri; Slim, Jihad; DeJesus, Edwin; Arora, Priyanka; Blair, Christiana; Hindman, Jason T; Wilkin, Aimee

Screening, brief intervention, and referral to treatment training for Nigerian primary care physicians: A pilot evaluation of knowledge, attitudes, self-efficacy, and barriers to implementation

针对尼日利亚基层医生开展筛查、简短干预和转诊治疗培训:一项关于知识、态度、自我效能和实施障碍的试点评估

Anaba, Honest; Thrul, Johannes; Oborevwori, Elohor; Oluwayomi, Osiyemi; Alexander, G Caleb

Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black and Hispanic/Latine adults with HIV-1 initiating first-line therapy: 5-year follow-up from two phase III studies

比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺在接受一线治疗的黑人和西班牙裔/拉丁裔 HIV-1 感染成人中的疗效和安全性:两项 III 期研究的 5 年随访结果

Martorell, C; Ramgopal, M; Hagins, D; Osiyemi, O; Arribas, J R; Berhe, M; Yazdanpanah, Y; Orkin, C; Santiago, L; Rosero, C; Unger, N; Liu, H; Rogers, R; Hindman, J T; Wurapa, A

When a little flutter gets a bit too exciting…

当小小的激动变得过于兴奋时……

Ali, Mohamed; Osiyemi, Ifeoluwade; Jackson, Matthew

Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial

在成人人类免疫缺陷病毒1型(HIV-1)感染者中,改用多替拉韦/拉米夫定双药方案与继续使用三药或四药方案维持病毒抑制的疗效和安全性:3期非劣效性SALSA随机试验第48周结果

Llibre, Josep M; Brites, Carlos; Cheng, Chien-Yu; Osiyemi, Olayemi; Galera, Carlos; Hocqueloux, Laurent; Maggiolo, Franco; Degen, Olaf; Taylor, Stephen; Blair, Elizabeth; Man, Choy; Wynne, Brian; Oyee, James; Underwood, Mark; Curtis, Lloyd; Bontempo, Gilda; van Wyk, Jean

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

早期使用瑞德西韦预防门诊新冠肺炎患者发展为重症

Gottlieb, Robert L; Vaca, Carlos E; Paredes, Roger; Mera, Jorge; Webb, Brandon J; Perez, Gilberto; Oguchi, Godson; Ryan, Pablo; Nielsen, Bibi U; Brown, Michael; Hidalgo, Ausberto; Sachdeva, Yessica; Mittal, Shilpi; Osiyemi, Olayemi; Skarbinski, Jacek; Juneja, Kavita; Hyland, Robert H; Osinusi, Anu; Chen, Shuguang; Camus, Gregory; Abdelghany, Mazin; Davies, Santosh; Behenna-Renton, Nicole; Duff, Frank; Marty, Francisco M; Katz, Morgan J; Ginde, Adit A; Brown, Samuel M; Schiffer, Joshua T; Hill, Joshua A

Efficacy and Safety of Switching to Dolutegravir/Lamivudine Versus Continuing a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Results Through Week 144 From the Phase 3, Noninferiority TANGO Randomized Trial

在成人人类免疫缺陷病毒1型感染者中,使用多替拉韦/拉米夫定方案与继续使用基于替诺福韦艾拉酚胺的3种或4种药物方案维持病毒抑制的疗效和安全性比较:来自3期非劣效性TANGO随机试验的144周结果

Osiyemi, Olayemi; De Wit, Stéphane; Ajana, Faïza; Bisshop, Fiona; Portilla, Joaquín; Routy, Jean Pierre; Wyen, Christoph; Ait-Khaled, Mounir; Leone, Peter; Pappa, Keith A; Wang, Ruolan; Wright, Jonathan; George, Nisha; Wynne, Brian; Aboud, Michael; van Wyk, Jean; Smith, Kimberly Y

Ibrutinib for Hospitalized Adults With Severe Coronavirus Disease 2019 Infection: Results of the Randomized, Double-Blind, Placebo-Controlled iNSPIRE Study

伊布替尼治疗重症冠状病毒病2019感染住院成人患者:随机、双盲、安慰剂对照iNSPIRE研究结果

Coutre, Steven E; Barnett, Christopher; Osiyemi, Olayemi; Hoda, Daanish; Ramgopal, Moti; Fort, Alexander C; Qaqish, Roula; Hu, Yiran; Ninomoto, Joi; Alami, Negar N; Styles, Lori; Treon, Steven P